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SUMMARY · Collecting duct carcinoma or Bellini duct carcinoma is a highly malignant neoplasm
that arises from the collecting duct epithelium of the kidney and accounts for approximately 1% of
renal neoplasms. Collecting duct carcinoma generally pursues a more aggressive course than conven-
tional renal cell carcinoma. Metastases to regional lymph nodes, bone, adrenal glands, lung, skin and
meninges have been reported. During the 1998-2000 period, 161 patients underwent nephrectomy
due to renal cell carcinoma at our hospital. The patients’ age ranged from 24 to 90 (mean 59.5) years.
There were 50 female and 111 male patients. Collecting duct carcinoma was diagnosed in three (1.9%)
male patients aged 79, 66 and 67 (mean age 71.0) years. The patients presented with hematuria as-
sociated with fever, weight loss, pain and palpable abdominal mass. On gross examination, the tu-
mors were located in the medulla of the kidney and extended into the cortex and adjacent adipose
tissue. Histologically, the tumors showed tubulopapillary, tubular or solid areas. Immunohisto-
chemically, positive staining with cytokeratin, EMA and Ulex Europaeus agglutinin was observed.
All patients had regional lymph node metastases, and two of them died within one month from
surgery. The third patient was alive and without signs of recurrence six months from presentation.
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Introduction
Collecting duct carcinoma (CDC) or Bellini duct
carcinoma is a neoplasm that arises from the collecting
duct epithelium of the kidney and accounts for 0.4% to
2.6% of all renal carcinomas1-3. This tumor is a histoge-
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netically, morphologically and cytogenetically defined
entity. CDC predominantly affects men, and a majority
of patients are white4. The average age of reported pa-
tients is approximately 53 years1,4,5. Tumors are mainly
located in the medulla or central part of the kidney. They
are white and gray and histologically show a tubular and
papillary pattern. CDC generally pursues a more aggres-
sive course than conventional renal cell carcinoma1,2. The
prognosis is poor, as more than 50% of the reported pa-
tients died within two years of presentation2,5,6. Meta-
stases to regional lymph nodes, bone, adrenal glands,
lung, skin and meninges have been reported4-6.
We present the clinicopathologic features of three
cases that were observed over the past three years.
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Patients and Methods
During a three-year period (1998-2000), 161 patients
underwent surgery at our hospital for renal cell carcinoma.
Tumors of the renal pelvis are not included. The patients
were aged 24-90 (mean age 59.5) years. There were 50
(31.1%) female and 111 (68.9%) male patients.
CDC was diagnosed in three (1.9%) male patients
aged 79, 66 and 67 (mean age 71.0) years. Clinical data
were obtained from the patients’ medical records. Follow-
up data to the last clinical examination or death were avail-
able in all three cases.
Formalin fixed, paraffin embedded tumor tissue was cut
at 5 µm sections, deparaffinized, and stained with hema-
toxylin and eosin. Immunohistochemistry was performed
on paraffin embedded archival material using primary an-
tibodies (cytokeratin, low molecular weight cytokeratin,
high molecular weight cytokeratin, EMA and Ulex
Europaeus agglutinin I) purchased from DAKO (Glostrup,
Denmark). The peroxidase/antiperoxidase method was
used with 3,3'-diaminobenzidine as a chromogen.
Case Reports
Case 1
A 79-year-old man with a history of left nephrectomy
for tuberculosis presented with sudden abdominal pain
and acute renal failure. Intraoperative findings showed a
tumor and massive hemorrhage from the right kidney.
The patient underwent radical nephrectomy. Enlarged re-
troperitoneal lymph nodes were observed. After surgery,
the patient underwent hemodialysis. The patient died
from renal failure three weeks after the surgery.
Case 2
A 66-year-old man presented with lumbar pain. Phy-
sical examination revealed a palpable left lumbar mass and
left cervical lymphadenopathy. Fine needle aspiration in-
dicated metastatic adenocarcinoma of cervical lymph no-
de. X-ray showed two metastatic nodules in the lung.
Computed tomography (CT) scan of the abdomen sho-
wed a large tumor in the left kidney and enlargement of
the hilar lymph nodes. The patient underwent radical ne-
phrectomy. Three weeks later, the patient died. Autopsy
revealed multiple metastases of the lungs and pulmonary
thromboembolism.
Case 3
A 67-year-old man presented with painless hematuria
lasting for the past two months. Urine cytology suggested
transitional cell carcinoma. CT scans of the abdomen sho-
wed a large tumor in the superior pole of the right kid-
ney, spreading to the pelvis. Radical nephrectomy with di-
ssection of regional lymph nodes was performed. The pa-
tient was free from recurrence six months after initial pre-
sentation.
Pathohistologic Findings
All tumors were located in the renal medulla and ex-
tended to the renal cortex. The tumors measured 8-10 cm
in largest diameter. One tumor was partly cystic with a
solid part in the medulla (case 1). The tumors had ill-
defined borders and showed infiltrative spread into the
renal and hilar tissues (Fig. 1). Renal capsule was touched
in two tumors. Tumor tissue was white or gray. Two tu-
mors showed necrotic areas. Two tumors had connection
with the pelvic transitional epithelium, and one of them
had papillary projections to the pelvis. There were no tu-
mor thrombi in the main renal veins.
Fig. 1. Kidney with ill-circumscribed, infiltrative, white tumor
extending from the renal pelvis to the renal capsule.
Tumor cells were relatively large with abundant,
weakly eosinophilic cytoplasm. The nuclei were large and
mainly vesicular with prominent eosinophilic nucleoli
(Fig. 2). The cells showed medium to high cytologic aty-
pia.The tumors showed cystic, papillary, tubular, solid and
cribriform growth patterns (Fig. 3). In one tumor, there
was intensive mononuclear stromal infiltration in papil-
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lary areas (case 2). In all tumors, desmoplastic stroma was
observed. There were no dysplastic changes in the adja-
cent collecting tubuli. Immunohistochemical studies
yielded positive results for CK, EMA and Ulex Europaeus
agglutinin.
All patients had regional node metastases. In one pa-
tient, cervical lymph node and pulmonary metastases were
also present (case 2). Histology of the regional lymph node
metastases was similar to the primary tumor pattern. Two
patients died within one month from surgery.
Discussion
To our knowledge, there are about 100 cases of CDC
reported in the English literature1-11. In 1974, Mancilla-
Jimenez et al.12 reported on a series of 34 papillary renal
cell carcinomas. They observed atypical and hyperplastic
changes in adjacent collecting tubuli in three tumors, and
hypothesized on their collecting duct origin. In 1979,
Cromie et al.13 described a renal tumor composed of pap-
illary, transitional and tubular cell component, and sug-
gested a collecting duct origin. However, according to Ke-
nnedy et al.6, one of the first descriptions of CDC was gi-
ven by Pierre Masson in his classical paper about human
tumors, published in 1955 in French. Many case reports
appeared in the meantime in the literature6,8,9,10,14,15. The
largest series comprised 12 cases5. CDC has recently been
recognized as a separate entity, and the latest World He-
alth Organization (WHO) classification designates it as
a distinct type16. In the previous WHO classification, this
tumor was grouped with renal cell carcinoma, with a sub-
designation ‘Bellini duct carcinoma’.
The average age of all patients reported in the literatu-
re is 54 (range 13-83) years. However, the tumor is frequ-
ently seen in the second and third decade of life, in a much
younger age group than conventional renal cell carcino-
ma4.The youngest patient was a 13-year-old girl reported
by O’Brien and Bedard14. The patient was followed for 5
years without clinical evidence of recurrence after nephre-
ctomy. The mean age of our patients was 71 years.
CDC shows a male predominance, with a male-to-
female ratio of approximately 2:14,5. All patients in our
series were men.
The proximal tubular cell is generally considered a cell
type giving rise to renal cell carcinoma. CDC arises from
the collecting duct epithelium of the kidney and shares a
common embryonic origin with renal pelvis and minor
and major calyces (mesonephros) rather than with proxi-
mal nephron (metanephros).
Histologically, CDC is characterized by papillary
structures suggesting transitional cell carcinoma, and glan-
dular areas suggesting renal cell carcinoma. However, a
sarcomatoid type of Bellini carcinoma has also been de-
scribed5,17. A panel of four immunohistochemical mark-
ers including CK 19, CK 13, vimentin and UEA-1 were
found to be useful in differentiating typical renal cell,
CDC and urothelial carcinomas2-4,18. The collecting duct
carcinoma cells share a similar phenotype (CK 19, UEA-
1, CK 13) with the collecting duct cells. CDC is also
positive for Ulex Europaeus and peanut lectin aggluti-
nin4,18. In contrast to typical renal cell carcinoma, CDC
is frequently mucicarmine positive3,4,18. Urothelial carci-
nomas express cytokeratin 13 and fail to express vimentin,
while in CDC the reactivity to vimentin is weak. Renal
cell carcinoma is usually positive for Leu-M1 (a proximal
Fig. 2. Collecting duct carcinoma of the kidney composed of atypical
epithelial cells with large vascular nuclei and prominent nucleoli
(HE x200).
Fig. 3. Collecting duct carcinoma showing a tubular and papillary
growth pattern (HE x100).
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tubule marker), low molecular weight cytokeratin and
vimentin4,18, but does not react with UEA-1. A panel of
antibodies could be used to differentiate this tumor from
conventional renal cell carcinoma and transitional cell
carcinoma.
The patients with CDC usually present with a widely
disseminated disease, while those having classic renal cell
carcinoma more commonly present with a localized dis-
ease2,5,18. Metastases to different organs have been repor-
ted, including bone and leptomeninges4,5,18. Bone metas-
tases usually are osteoblastic5.
The majority of reported patients were treated by ne-
phrectomy and regional lymph node dissection. However,
seven of 12 patients reported by Dimopoulos et al.5 were
administered chemotherapy consisting of various combi-
nations of chemotherapeutic agents, mostly MVAC
(methotrexate, vinblastine, doxorubicin and cisplatin).
Four of these seven patients were initially diagnosed as
atypical papillary transitional cell carcinoma of the pel-
vis. No response was achieved by this combination che-
motherapy. Six patients were treated with interleukin-2
and interferon-α, and one of these patients showed no evi-
dence of the disease at 30 months from surgery5.
At present, the number of reported cases of CDC is
too small and with a short follow-up to make any real sur-
vival assessment. However, the cases reported in this se-
ries as well as those described elsewhere point to poor
prognosis. Unfortunately, at present there does not seem
to be any efficacious systemic treatment for CDC.
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Saæetak
KARCINOM BUBREÆNOG SABIRNOG KANALA: PRIKAZ TRIJU SLU»AJEVA
B. Kru¹lin, I. GlumbiÊ, A. ReljiÊ, H. »upiÊ, B. RuæiÊ, G. ©timac i M. Belicza
Karcinom sabirnog kanala ili karcinom Bellinijeva kanala je visoko maligna neoplazma koja nastaje iz epitela bubreænoga
sabirnog kanala i Ëini otprilike 1% bubreænih neoplazma. Karcinom sabirnoga kanala uglavnom ima agresivniji tijek od
konvencionalnog karcinoma bubreænih stanica. Opisane su metastaze u regionalne limfne Ëvorove, kosti, nadbubreæne ælijezde,
pluÊa, koæu i meninge. U razdoblju od 1998. do 2000. godine u na¹oj je bolnici 161 bolesnik podvrgnut nefrektomiji zbog
karcinoma bubreænih stanica. Bolesnici su bili u dobi od 24 do 90 godina (srednja dob 59,5 godina), a bilo je 50 æena i 111
mu¹karaca. Karcinom sabirnog kanala dijagnosticiran je u trojice (1,9%) mu¹kih bolesnika u dobi od 79, 66 i 67 godina (srednja
dob 71,0 godina). Bolesnici su do¹li s hematurijom udruæenom s groznicom, gubitkom teæine, bolovima i opipljivom masom
u trbu¹noj ¹upljini. Makroskopskim pregledom su tumori locirani u bubreænoj meduli, a protezali su se u koru i obliænje masno
tkivo. Histolo¹ki su tumori pokazivali tubulopapilarna, tubularna ili kruta podruËja. Imunohistokemijski je zabiljeæeno pozitivno
bojenje citokeratinom, EMA i Ulex Europaeus aglutininom. Svi su bolesnici imali metastaze regionalnih limfnih Ëvorova, a
dvojica su umrla kroz mjesec dana nakon operacije. TreÊi je bolesnik bio æiv i bez znakova ponovljene bolesti ¹est mjeseci nakon
dolaska u bolnicu.
KljuËne rijeËi: Neoplazme bubrega, patologija; Neoplazme bubrega, dijagnostika
